ACP-01, autologous angiogenic precursor cells for critical limb ischemia

ACP-01 is a product comprised of autologous angiogenic peripheral blood-derived precursor cells, expanded ex vivo for the treatment of critical limb ischemia. The treatment was found to be safe in a small-scale clinical trial and improved circulation in patients.